Literature DB >> 33902384

Whole blood transfusion reduces overall component transfusion in cases of placenta accreta spectrum: a pilot program.

Jessian L Munoz1,2, Alison M Kimura1,2, Elly Xenakis1,2, Donald H Jenkins3, Maxwell A Braverman3, Patrick S Ramsey1,2, Kayla E Ireland1,2.   

Abstract

OBJECTIVE: Placenta accreta spectrum (PAS) is a group of placental invasion pathologies associated with significant morbidity to both mother and fetus. The majority of patients with PAS will require a blood transfusion at time of delivery and subsequent cesarean hysterectomy. The optimal approach to maternal acute blood loss resuscitation is currently unknown.
METHODS: Here, we present a cohort analysis of 34 patients with pathology-confirmed PAS treated with either whole blood (n = 16) or component therapy (n = 18) for initial intraoperative resuscitation.
RESULTS: We observed comparable results in post-operative outcomes with fewer overall transfusions and subsequently, lower volumes of resuscitation (p=.03) with whole blood initial resuscitation.
CONCLUSIONS: Whole blood transfusion may represent a viable option for initial resuscitation with lower resuscitation volumes and transfusion-associated complications without directly effecting post-operative outcomes in cases of PAS.

Entities:  

Keywords:  Placenta accreta; abnormal placentation; blood transfusion; cesarean hysterectomy; whole blood

Year:  2021        PMID: 33902384     DOI: 10.1080/14767058.2021.1915275

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  2 in total

1.  Recent Developments in Emergency Blood Transfusion.

Authors:  Hans-Gert Heuft; Mark H Yazer
Journal:  Transfus Med Hemother       Date:  2021-10-28       Impact factor: 3.747

Review 2.  The Role of Whole Blood Transfusions in Civilian Trauma: A Review of Literature in Military and Civilian Trauma.

Authors:  Shane Kronstedt; Joon Lee; David Millner; Connor Mattivi; Halli LaFrankie; Lorenzo Paladino; Jeffrey Siegler
Journal:  Cureus       Date:  2022-04-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.